Skip to main content
. 2011 Oct 5;53(12):1256–1264. doi: 10.1093/cid/cir673

Table 5.

Correlates of Increasing Multimorbidity Among ALIVE Study Participants (N = 1262)

Unadjusted OR (95% CI)a P value Adjusted OR (95% CI)a P value
Age (per 1-year increase) 1.06 (1.04–1.07) <.001 1.06 (1.04–1.07) <.001
Sex
    Male ref ref
    Female 1.10 (.890–1.35) .388 1.29 (1.04–1.60) .023
Race
    White/Other ref
    African-American 1.86 (1.37–2.53) <.001
Marital statusb
    Never married ref
    Ever married 1.22 (0.989–1.50) .064
Employedc
    No ref
    Yes 0.941 (.744–1.19) .612
Homelessc
    No ref
    Yes 0.813 (.615–1.07) .144
Cigarette smokerc
    No ref ref
    Yes 0.599 (.458–.784) <.000 0.697 (.527–.923) .012
No. alcoholic drinks/dayc
    0 ref
    1–2 0.734 (.579–.930) .011
    3–4 0.770 (.575–1.03) .079
    ≥5 1.00 (.695–1.45) .981
Drug userc
    No ref ref
    Noninjection only 0.639 (.483–.845) .002 0.672 (.502–.900) .008
    Injection only 0.652 (.481–.883) .006 0.753 (.550–1.03) .075
    Both 0.478 (.371–.616) <.001 0.600 (.458–.787) <.001
Depressive symptoms
    CES-D <23 ref ref
    CES-D ≥23 1.18 (.926–1.50) .180 1.44 (1.11–1.85) .005
HIV status
    HIV negative ref ref
    HIV positive 1.99 (1.60–2.49) <.001 1.50 (1.13–1.99) .005
Current CD4 T-cell countd 1.11 (1.03–1.20) .007
CD4 T-cell nadird 1.18 (1.04–1.34) .003 1.14 (1.00–1.29) .046
HIV log10 HIV RNAe 1.19 (0.988–1.44) .067 1.32 (1.08–1.60) .006

Abbreviations: ALIVE, AIDS Linked to the IntraVenous Experience study; CES-D, Center for Epidemiologic Studies Depression Scale; CI, confidence interval; HIV, human immunodeficiency virus; OR, odds ratio.

a

Univariate and multivariate proportional odds model: Under the proportional odds assumption, the estimated OR applies to any of the 3 ORs being modeled; that is, we estimate the OR for ≥1 conditions relative to 0, the OR for ≥2 conditions relative to 0–1, or the OR for ≥3- conditions relative to 0–2.

b

At enrollment.

c

In prior 6 months.

d

Per 100-cell decrease (centered at 200 cells/mm3).

e

Per log10 copies/mL increase (centered at 2.60, level of detection).

HHS Vulnerability Disclosure